WILYY (Demant AS) Accounts Receivable: $650 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WILYY Demant AS WILYY
95 GF Score
Price $23.00
GF Value $22.31
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Demant AS Accounts Receivable?

Demant AS WILYY +2.22% 95 Accounts Receivable is $650 Mil as of Jun. 2026. GuruFocus rates WILYY with a GF Score™ of 95/100 and a GF Value™ of $22.31 (Fairly Valued). The stock has 5 warning signs investors should review.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Demant AS's accounts receivables for the quarter that ended in Jun. 2026 was $650 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Demant AS's Days Sales Outstanding for the quarter that ended in Jun. 2026 was 59.60.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Demant AS's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was $-8.30.


Demant AS Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Demant AS's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=649.739/1989.584*91
=59.60

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Demant AS's accounts receivable are only considered to be worth 75% of book value:

Demant AS's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(230.498+0.75 * 649.739+0.5 * 432.492-4423.216
-0-11.71)/421.797
=-8.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Demant AS Accounts Receivable Related Terms


Demant AS Accounts Receivable Historical Data

* Premium members only.

The historical data trend for Demant AS's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Demant AS Accounts Receivable Chart

Demant AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 486.70 516.31 534.03 500.27 590.27

Demant AS Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 534.35 500.27 541.59 590.27 649.74
WILYY
95GF Score
Demant AS WILYY
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Demant AS Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of $650 Mil mean?
Demant AS (WILYY) has a Accounts Receivable of $650 Mil as of Jun. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Demant AS and its competitors.
Is Demant AS's Accounts Receivable too high?
Demant AS's current Accounts Receivable is $650 Mil. Overall, Demant AS has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Demant AS's Accounts Receivable compare to ABT and SYK?
Demant AS's Accounts Receivable of $650 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Medical Devices & Instruments company?
A good Accounts Receivable depends on the Medical Devices & Instruments industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Demant AS and its competitors. Demant AS's current Accounts Receivable is $650 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Demant AS stock overvalued right now?
Based on GuruFocus' analysis, Demant AS (WILYY) is currently considered Fairly Valued. The stock's GF Value™ is $22.31, compared to a current price of $23.00 — trading 3.1% above its estimated fair value. The current Accounts Receivable is $650 Mil. Demant AS's overall GF Score™ is 95/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Demant AS (WILYY), the current Accounts Receivable is $650 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Demant AS (WILYY) Overvalued in 2026?

Based on GuruFocus' analysis, Demant AS stock appears to be overvalued. The current stock price of $23.00 is trading 3.1% above its estimated GF Value™ of $22.31. GuruFocus considers Demant AS to be Fairly Valued.

Key valuation signals for WILYY:

  • Accounts Receivable: $650 Mil
  • GF Value™: $22.31 vs. price of $23.00 (3.1% above fair value)
  • GF Score™: 95/100 with 5 warning signs

No single metric tells the full story. See the WILYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Demant AS Business Description

Address Kongebakken 9, Smorum, DNK, 2765
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
95GF Score

Get the complete analysis for WILYY

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.00
Price
$22.31
GF Value